You are here

Clinical Trials: Central Nervous System Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, January 26, 2023 - 12:00
Conditions:   Multiple System Atrophy;   MSA - Multiple System Atrophy
Interventions:   Drug: hOMSC300;   Other: Sham Procedure
Sponsor:   Cytora Ltd.
Posted: Thursday, January 26, 2023 - 12:00
Condition:   Ischemic Stroke
Intervention:   Biological: MSC
Sponsor:   Shanghai IxCell Biotechnology Co., LTD
Not yet recruiting
Posted: Friday, January 20, 2023 - 12:00
Condition:   Spinal Cord Injury, Acute
Interventions:   Biological: Multiple systemic (i.v.) administration of allogenic non-related group- and rhesus-compatible mononuclear cord blood cells;   Other: Control vehicle (sterile saline)
Sponsors:   Sklifosovsky Institute of Emergency Care;   State-Financed Health Facility "Samara Regional Medical Center Dinasty";   K.L. Hetagurov North-Osetian State University
Posted: Thursday, January 19, 2023 - 12:00
Condition:   Idiopathic Parkinson's Disease
Intervention:   Biological: hAESCs
Sponsors:   Shanghai East Hospital;   Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Not yet recruiting
Posted: Wednesday, December 28, 2022 - 12:00
Condition:   Alzheimer Disease
Intervention:   Biological: RB-ADSC
Sponsor:   Regeneration Biomedical, Inc.
Not yet recruiting
Posted: Friday, December 2, 2022 - 12:00
Condition:   Parkinson Disease
Intervention:   Biological: STEM-PD
Sponsors:   Region Skane;   Lund University;   Cambridge University Hospitals NHS Foundation Trust;   University of Cambridge
Not yet recruiting
Posted: Friday, September 23, 2022 - 12:00
Conditions:   Spinal Cord Injuries;   Tetraplegia
Intervention:   Device: Testing of MyHand-SCI Device
Sponsors:   Columbia University;   National Institute of Neurological Disorders and Stroke (NINDS)
Posted: Thursday, September 15, 2022 - 12:00
Condition:   Progressive Multifocal Leukoencephalopathy
Intervention:   Biological: CE-VST01-JC
Sponsor:   Cellevolve Bio Inc
Not yet recruiting
Posted: Wednesday, August 24, 2022 - 12:00
Conditions:   Hypoxic-Ischemic Encephalopathy;   Neonatal Asphyxia;   Neonatal Encephalopathy
Interventions:   Drug: Normal Saline along with standard treatment;   Drug: Sovateltide along with standard treatment
Sponsor:   Pharmazz, Inc.
Not yet recruiting
Posted: Thursday, August 11, 2022 - 12:00
Condition:   Brain Concussion
Intervention:   Behavioral: Aerobic Exercise
Sponsors:   State University of New York at Buffalo;   United States Department of Defense;   Children's Hospital of Philadelphia;   University of Pennsylvania;   University of North Carolina, Chapel Hill;   Geneva Foundation;   Quadrant Biosciences Inc.;   Center for Neuroscience and Regenerative Medicine (CNRM);   Axon Medical Technologies LLC
Not yet recruiting